Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.
Christian AnholmPreman KumarathuraiMalene S KlitOle P KristiansenOlav W NielsenSteen LadelundSten MadsbadAhmad SajadiehSteen B Haugaardnull nullPublished in: BMJ open (2014)
Clinicaltrials.gov ID: NCT01595789, EudraCT: 2011-005405-78.